Identification of novel natural inhibitors targeting AKT Serine/Threonine Kinase 1 (AKT1) by computational study

Author:

Zhong Sheng1,Hou Yuanyuan2,Zhang Zhiyun2,Guo Zhen2,Yang Wenzhuo2,Dou Gaojing3,Lv Xiaye4,Wang Xinhui5,Ge Junliang2,Wu Bo6,Pan Xuefeng7,Wang Hongyu2,Yang Qunying1,Mou Yonggao1

Affiliation:

1. Neurosurgery and Neuro-Oncology Department, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China

2. Clinical College, Jilin University, Changchun, China

3. Department of Breast surgery, the First Bethune Hospital of Jilin University, Changchun, China

4. Department of Hematology, the First Clinical Medical School of Lanzhou University, Lanzhou, Gansu, China

5. Department of Oncology, the First Hospital of Jilin University, Changchun, China

6. Department of Orthopaedics, the First Bethune Hospital of Jilin University, Changchun, China

7. Department of Obstetrics, the First Bethune Hospital of Jilin University, Changchun, China

Funder

Science and Technology Planning Project of Guangdong Province, China

Science and Technology Program of Guangzhou, China

Scientific and Technological Achievement Transformation Project of Sun Yat-sen University, China

National Natural Science Foundation of China

Science and Technology Program of Jiangmen, China

Publisher

Informa UK Limited

Subject

Applied Microbiology and Biotechnology,General Medicine,Bioengineering,Biotechnology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3